Renalytix plc financial data

Symbol
RNLX on Nasdaq, RTNXF on OTC
Industry
Services-Medical Laboratories
Location
Finsgate, 5 7 Cranwood Street, London, United Kingdom
State of incorporation
Delaware
Fiscal year end
June 30
Former names
Renalytix AI plc (to 6/25/2021)
Latest financial report
10-Q - Q1 2024 - May 15, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 96.2 % -63.2%
Debt-to-equity -617 % -669%
Return On Equity 1.1K %
Return On Assets -214 % -114%
Operating Margin -1.53K % -25.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 154M shares
Common Stock, Shares, Outstanding 120M shares +27.9%
Entity Public Float 44.9M USD
Common Stock, Value, Issued 368K USD +28.7%
Weighted Average Number of Shares Outstanding, Basic 97.7M shares +14.1%
Weighted Average Number of Shares Outstanding, Diluted 97.7M shares +14.1%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 2.22M USD -40.2%
Cost of Revenue 2.26M USD -16.5%
General and Administrative Expense 21.8M USD -33.4%
Operating Income (Loss) -34M USD +25%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -37.5M USD +5.44%
Income Tax Expense (Benefit) 6K USD -76%
Net Income (Loss) Attributable to Parent -37.5M USD +5.47%
Earnings Per Share, Basic -0.39 USD/shares +23.5%
Earnings Per Share, Diluted -0.39 USD/shares +30.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 4.7M USD -85.8%
Accounts Receivable, after Allowance for Credit Loss, Current 554K USD -25.8%
Assets, Current 6.34M USD -82.3%
Property, Plant and Equipment, Net 230K USD -89.5%
Operating Lease, Right-of-Use Asset 0 USD -100%
Intangible Assets, Net (Excluding Goodwill) 913K USD
Assets 8.77M USD -78%
Accounts Payable, Current 1.75M USD -15.1%
Employee-related Liabilities, Current 1.05M USD -72.1%
Accrued Liabilities, Current 4.27M USD -27.2%
Liabilities, Current 15M USD +2.07%
Operating Lease, Liability, Noncurrent 0 USD -100%
Other Liabilities, Noncurrent 14K USD
Liabilities 19.9M USD -8.41%
Accumulated Other Comprehensive Income (Loss), Net of Tax -1.56M USD -85.7%
Retained Earnings (Accumulated Deficit) -205M USD -22.4%
Stockholders' Equity Attributable to Parent -11.1M USD -161%
Liabilities and Equity 8.77M USD -78%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -9.5M USD -33.5%
Net Cash Provided by (Used in) Financing Activities -1.07M USD -12.8%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 128M shares +29.3%
Common Stock, Shares, Issued 120M shares +27.9%
Common Stock, Par or Stated Value Per Share 0 GBP/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -10.8M USD -4.84%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 41.3M USD -36.5%
Interest Paid, Excluding Capitalized Interest, Operating Activities 292K USD
Deferred Tax Assets, Valuation Allowance 45.6M USD +46.6%
Operating Lease, Liability 78K USD -61%
Depreciation 220K USD -26.7%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -17.3M USD -128%
Lessee, Operating Lease, Liability, to be Paid 81K USD
Property, Plant and Equipment, Gross 515K USD -84.7%
Operating Lease, Liability, Current 78K USD -39.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year One 81K USD
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 3K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 0 USD
Deferred Tax Assets, Operating Loss Carryforwards 37.7M USD +38.7%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 0 USD
Operating Lease, Payments 67K USD -65.6%
Operating Leases, Future Minimum Payments, Due in Two Years 153K USD +84.3%
Depreciation, Depletion and Amortization 127K USD -2.31%
Operating Leases, Future Minimum Payments Due, Next Twelve Months 162K USD
Deferred Tax Assets, Net of Valuation Allowance 453K USD -21.6%
Share-based Payment Arrangement, Expense 1.88M USD -54.7%
Operating Leases, Future Minimum Payments, Due in Three Years 45K USD -45.8%
Operating Leases, Future Minimum Payments Due 360K USD +30%